XML Financial LLC Has $380,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

XML Financial LLC lessened its position in iShares Biotechnology ETF (NASDAQ:IBB) by 8.3% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 2,767 shares of the financial services provider’s stock after selling 251 shares during the period. XML Financial LLC’s holdings in iShares Biotechnology ETF were worth $380,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in IBB. International Assets Investment Management LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $563,000. Tennessee Valley Asset Management Partners bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $44,000. Calamos Advisors LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $7,648,000. abrdn plc bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $5,928,000. Finally, Signaturefd LLC boosted its position in shares of iShares Biotechnology ETF by 14.2% during the 4th quarter. Signaturefd LLC now owns 1,120 shares of the financial services provider’s stock valued at $152,000 after acquiring an additional 139 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of iShares Biotechnology ETF stock traded up $0.77 during trading on Wednesday, hitting $148.15. 751,839 shares of the company’s stock traded hands, compared to its average volume of 1,580,583. The firm’s fifty day moving average price is $141.56 and its 200 day moving average price is $136.94. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.17.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.